Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1

Interventions

Peripheral Blood Stem Cell Transplantation 7Cyclosporine 6Methotrexate 5fludarabine phosphate 4Cyclophosphamide 4Busulfan 4Tacrolimus 3Radiotherapy 3Whole-Body Irradiation 2Pentetic Acid 2Mycophenolic Acid 2Idarubicin 2Filgrastim 2Cytarabine 2Cyclosporins 2Antilymphocyte Serum 2merphos 1ethanolamine oleate 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Therapeutics 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Pentostatin 1Minocycline 1Methylprednisolone 1Melphalan 1Interferon-gamma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myeloid, Chronic-Phase × Interferon-gamma × Clear all
NCT00002761 2012-11-19

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Columbia University

Phase 1/2 Withdrawn
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡